These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11521073)

  • 41. Endotoxin suppresses mouse hepatic low-density lipoprotein-receptor expression via a pathway independent of the toll-like receptor 4.
    Liao W; Rudling M; Angelin B
    Hepatology; 1999 Nov; 30(5):1252-6. PubMed ID: 10534347
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors.
    Pinhal-Enfield G; Ramanathan M; Hasko G; Vogel SN; Salzman AL; Boons GJ; Leibovich SJ
    Am J Pathol; 2003 Aug; 163(2):711-21. PubMed ID: 12875990
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential recognition of structural details of bacterial lipopeptides by toll-like receptors.
    Morr M; Takeuchi O; Akira S; Simon MM; Mühlradt PF
    Eur J Immunol; 2002 Dec; 32(12):3337-47. PubMed ID: 12432564
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NADPH oxidase NOX2 mediates TLR2/6-dependent release of GM-CSF from endothelial cells.
    Schuett J; Schuett H; Oberoi R; Koch AK; Pretzer S; Luchtefeld M; Schieffer B; Grote K
    FASEB J; 2017 Jun; 31(6):2612-2624. PubMed ID: 28274989
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IFN-gamma is a master regulator of endotoxin shock syndrome in mice primed with heat-killed Propionibacterium acnes.
    Kawa K; Tsutsui H; Uchiyama R; Kato J; Matsui K; Iwakura Y; Matsumoto T; Nakanishi K
    Int Immunol; 2010 Mar; 22(3):157-66. PubMed ID: 20130231
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Mycoplasma-derived lipopeptide MALP-2 is a potent mucosal adjuvant.
    Rharbaoui F; Drabner B; Borsutzky S; Winckler U; Morr M; Ensoli B; Mühlradt PF; Guzmán CA
    Eur J Immunol; 2002 Oct; 32(10):2857-65. PubMed ID: 12355438
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo effects of a synthetic 2-kilodalton macrophage-activating lipopeptide of Mycoplasma fermentans after pulmonary application.
    Lührmann A; Deiters U; Skokowa J; Hanke M; Gessner JE; Mühlradt PF; Pabst R; Tschernig T
    Infect Immun; 2002 Jul; 70(7):3785-92. PubMed ID: 12065522
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mycoplasma fermentans and TNF-beta interact to amplify immune-modulating cytokines in human lung fibroblasts.
    Fabisiak JP; Gao F; Thomson RG; Strieter RM; Watkins SC; Dauber JH
    Am J Physiol Lung Cell Mol Physiol; 2006 Oct; 291(4):L781-93. PubMed ID: 16751226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calpastatin is upregulated in non-immune neuronal cells via toll-like receptor 2 (TLR2) pathways by lipid-containing agonists.
    Vaisid T; Kosower NS
    Biochim Biophys Acta; 2013 Oct; 1833(10):2369-77. PubMed ID: 23773963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lipid-associated membrane proteins of Mycoplasma fermentans and M. penetrans activate human immunodeficiency virus long-terminal repeats through Toll-like receptors.
    Shimizu T; Kida Y; Kuwano K
    Immunology; 2004 Sep; 113(1):121-9. PubMed ID: 15312143
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Toll-like receptor 4 expression levels determine the degree of LPS-susceptibility in mice.
    Kalis C; Kanzler B; Lembo A; Poltorak A; Galanos C; Freudenberg MA
    Eur J Immunol; 2003 Mar; 33(3):798-805. PubMed ID: 12616500
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Panax ginseng induces production of proinflammatory cytokines via toll-like receptor.
    Nakaya TA; Kita M; Kuriyama H; Iwakura Y; Imanishi J
    J Interferon Cytokine Res; 2004 Feb; 24(2):93-100. PubMed ID: 14980073
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential posttranslational processing confers intraspecies variation of a major surface lipoprotein and a macrophage-activating lipopeptide of Mycoplasma fermentans.
    Calcutt MJ; Kim MF; Karpas AB; Mühlradt PF; Wise KS
    Infect Immun; 1999 Feb; 67(2):760-71. PubMed ID: 9916088
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Attenuated pathogenesis of polymicrobial peritonitis in mice after TLR2 agonist pre-treatment involves ST2 up-regulation.
    Feterowski C; Novotny A; Kaiser-Moore S; Mühlradt PF; Rossmann-Bloeck T; Rump M; Holzmann B; Weighardt H
    Int Immunol; 2005 Aug; 17(8):1035-46. PubMed ID: 16000329
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Direct stimulatory effects of the TLR2/6 ligand bacterial lipopeptide MALP-2 on neutrophil granulocytes.
    Wilde I; Lotz S; Engelmann D; Starke A; van Zandbergen G; Solbach W; Laskay T
    Med Microbiol Immunol; 2007 Jun; 196(2):61-71. PubMed ID: 17006695
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pyrexia, anorexia, adipsia, and depressed motor activity in rats during systemic inflammation induced by the Toll-like receptors-2 and -6 agonists MALP-2 and FSL-1.
    Hübschle T; Mütze J; Mühlradt PF; Korte S; Gerstberger R; Roth J
    Am J Physiol Regul Integr Comp Physiol; 2006 Jan; 290(1):R180-7. PubMed ID: 16154916
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD36 is a sensor of diacylglycerides.
    Hoebe K; Georgel P; Rutschmann S; Du X; Mudd S; Crozat K; Sovath S; Shamel L; Hartung T; Zähringer U; Beutler B
    Nature; 2005 Feb; 433(7025):523-7. PubMed ID: 15690042
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection.
    Lorenz E; Mira JP; Cornish KL; Arbour NC; Schwartz DA
    Infect Immun; 2000 Nov; 68(11):6398-401. PubMed ID: 11035751
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lipopolysaccharide recognition, CD14, and lipopolysaccharide receptors.
    Ingalls RR; Heine H; Lien E; Yoshimura A; Golenbock D
    Infect Dis Clin North Am; 1999 Jun; 13(2):341-53, vii. PubMed ID: 10340170
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pushing the envelope: Immune mechanism and application landscape of macrophage-activating lipopeptide-2.
    Liao D; Su X; Wang J; Yu J; Luo H; Tian W; Ye Z; He J
    Front Immunol; 2023; 14():1113715. PubMed ID: 36761746
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.